Featured News

Climber with diabetes on Aconcagua

“Climbing with diabetes requires stamina, special physical skills and a good physical feeling.” Andreas Hüsch knows, what he is talking about: he has type 1 diabetes. Yet, Hüsch has just climbed the Aconcagua - with 6,962 meters the highest mountain in the Americas. His first big tour to one of the Seven Summits led him to an altitude of 6,600 meters – and therewith almost to the summit.

» more

Behind the scenes: Turning a product into a familiar friend

What works all over the globe regardless of language barriers? Brands! Good branding makes people think of a certain brand as soon as they see a specific color, symbol or picture – even without seeing its name. But it’s not easy. Global Brand Teams for Bayer HealthCare’s pharmaceutical products have to create a consistent experience around the world across completely different cultures, traditions and markets.

» more

Drugs’ journey through the body

How does a drug reach the place where it’s needed inside the body in the right concentration? With many different models, Bayer HealthCare colleagues in Drug Metabolism & Pharmacokinetics (DMPK) work on precise predictions on how a substance will behave in the human body – long before the first trials with patients begin.

» more

An application with 15 gigabytes

Several thousand files, more than 15 gigabytes – it’s almost impossible to imagine how much work goes into a carefully prepared dossier to apply for the approval of a drug. Compiling, evaluating and documenting all this data on a product’s safety, efficacy and pharmaceutical quality is the central task for Global Regulatory Affairs (GRA) at Bayer HealthCare. » more

Only the safe ones will survive

The toxicology experts in Global Early Development (GED) at Bayer HealthCare are the “safety gate” for new substances. They investigate their effects and risks long before the first clinical trials – making sure that only safe active ingredients are tested on humans and remain candidates for new drugs.

» more

Joining forces for better research

Imagine everyone would join forces to improve pharmaceutical research: companies, policymakers, associations, patient groups and academia. What a powerful tool this would be! It’s happening through IMI, the Innovative Medicines Initiative, founded by the European Commission, the European Association of Pharmaceutical Industries and Associations (EFPIA) and academic partners. Bayer HealthCare is part of many IMI projects.

» more

Pharmacovigilance: Minimizing the risk of side effects

Drugs have to be effective. But it is just as important that they are safe. Global Pharmacovigilance at Bayer HealthCare with its international team of Global Safety Leaders conducts extensive studies in order to make sure that the potential side effects of a drug are kept to a minimum – so that as many patients as possible can really benefit from effective medication.

» more

Common Mechanism Research: a second career for active substances

The same drug to ease headaches and prevent heart attacks? Various diseases have common underlying mechanisms and therefore require similar drugs. But to find out that a particular substance successfully treating a certain disease can also help patients with a completely different diagnosis entails a great amount of research. That’s the work of Bayer HealthCare’s Common Mechanism Research (CMR) team.

» more

Behind the scenes: Study design provides the roadmap for developing new substances

On the long road from an active substance to an effective drug, Global Clinical Development at Bayer HealthCare, dealing with the design and conduct of studies makes sure that the right studies are being conducted. What are the goals of a certain study, what are the conditions, who can take part? The colleagues in study design find the answers to all these questions.

» more

“Afrika kommt!” initiative – Bayer sponsors internships for talented young managers from Africa

19 German companies, including Bayer, have sponsored internships for young managers from African countries. The initiative “Afrika kommt!” (“Here comes Africa!”) aims to support young African managers to boost their skills, to build up active networks and to advance economic cooperation between Africa and Germany. It was first launched in 2008 under the patronage of the then Federal President Horst Köhler.

» more